CalciMedica (CALC) Shares Outstanding (2019 - 2026)
CalciMedica's (CALC) quarterly Shares Outstanding (Entity) came in at $15.7 million in Q1 2026, up 12.7% YoY from $14.0 million in Q1 2025, and up 2.0% on a QoQ basis from $15.4 million in Q4 2025.
CalciMedica (CALC) Shares Outstanding (2019 - 2026) Analysis & Trends
CalciMedica (CALC) has 8 years of Shares Outstanding (Entity) data on file, last reported at $15.7 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 12.7% year-over-year to $15.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.7 million (up 12.7% YoY) and the FY2025 annual result came in at $15.4 million, up 14.5% from the prior year.
- Shares Outstanding (Entity) improved to $15.7 million in Q1 2026, from $15.4 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $15.7 million in Q1 2026 to a low of $823069.0 in Q1 2023.
- A 5-year average of $8.3 million and a median of $10.7 million in 2024 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) sank 46.05% — and 2024, when it surged 1204.89%.
- Tracing CALC's Shares Outstanding (Entity) over 5 years: stood at $1.5 million in 2022, then jumped by 192.27% to $4.5 million in 2023, then surged by 200.52% to $13.5 million in 2024, then advanced by 14.5% to $15.4 million in 2025, then gained by 2.0% to $15.7 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $15.7 million (Q1 2026), $15.4 million (Q4 2025), and $14.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 133.61 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 217.35 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 445.06 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 241.70 Mn |
| 10 | CalciMedica | 9.93 Mn | -8.69 Mn | - | 17.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.10 Mn |
| Mar 31, 2026 | 15.82 Mn |
| Dec 31, 2025 | 15.01 Mn |
| Sep 30, 2025 | 15.08 Mn |
| Jun 30, 2025 | 15.00 Mn |
| Mar 31, 2025 | 14.12 Mn |
| Dec 31, 2024 | 11.25 Mn |
| Sep 30, 2024 | 11.13 Mn |
| Jun 30, 2024 | 11.13 Mn |
| Mar 31, 2024 | 9.75 Mn |
| Dec 31, 2023 | 4.49 Mn |
| Sep 30, 2023 | 5.67 Mn |
| Jun 30, 2023 | 5.66 Mn |
| Mar 31, 2023 | 823,069.00 |
| Dec 31, 2022 | 1.53 Mn |
| Sep 30, 2022 | 1.54 Mn |
| Jun 30, 2022 | 1.53 Mn |
| Mar 31, 2022 | 1.53 Mn |
| Dec 31, 2021 | 1.51 Mn |
| Sep 30, 2021 | 1.52 Mn |